A detailed history of Voloridge Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 289,735 shares of BMY stock, worth $16.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
289,735
Previous 2,860,613 89.87%
Holding current value
$16.7 Million
Previous $119 Million 87.38%
% of portfolio
0.06%
Previous 0.45%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $102 Million - $133 Million
-2,570,878 Reduced 89.87%
289,735 $15 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $5.81 Million - $7.66 Million
144,469 Added 5.32%
2,860,613 $119 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $109 Million - $124 Million
-2,274,027 Reduced 45.57%
2,716,144 $147 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $129 Million - $154 Million
2,664,152 Added 114.54%
4,990,171 $256 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $26.1 Million - $29.2 Million
451,621 Added 24.09%
2,326,019 $135 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $112 Million - $124 Million
1,753,484 Added 1450.19%
1,874,398 $120 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $12.8 Million - $14.5 Million
-194,105 Reduced 61.62%
120,914 $8.38 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $3.19 Million - $3.78 Million
46,580 Added 17.35%
315,019 $22.7 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $186,067 - $110 Million
-1,431,291 Reduced 84.21%
268,439 $19.1 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $123 Million - $136 Million
1,699,730 New
1,699,730 $131 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $44.4 Million - $52 Million
-749,804 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $18.3 Million - $19.9 Million
294,875 Added 64.82%
749,804 $50.1 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $11.6 Million - $13 Million
195,378 Added 75.28%
454,929 $28.7 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $9.08 Million - $10.3 Million
157,315 Added 153.87%
259,551 $16.1 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $25.5 Million - $28.3 Million
-444,033 Reduced 81.28%
102,236 $6.16 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $29.9 Million - $35 Million
546,269 New
546,269 $32.1 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $17.6 Million - $22.9 Million
-356,662 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $15.3 Million - $18.1 Million
356,662 New
356,662 $18.1 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $33 Million - $36.5 Million
-739,674 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $33.4 Million - $39.8 Million
739,674 New
739,674 $35.3 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $157,738 - $204,549
-3,235 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $178,539 - $201,378
3,235 New
3,235 $201,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $5.63 Million - $6.49 Million
-94,036 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $831,247 - $906,273
-13,868 Reduced 12.85%
94,036 $5.76 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $5.96 Million - $6.88 Million
107,904
107,904 $6.88 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.